Figure 4 | Scientific Reports

Figure 4

From: BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients

Figure 4

Images in a 42-year-old man diagnosed with GBM and a high level (204.9) of BCAT1 expression. (A) The tumor showed high nCBV and low ADC values from both FLAIR (Top line, mean nCBV: 6.86, mean ADC: 1211.26 × 10−6 mm2/sec) and contrast enhanced T1W1 (Bottom line, mean nCBV: 11.00, mean ADC: 1225.30 × 10−6 mm2/sec). The yellow and light purple ROIs indicate the entire tumor areas on FLAIR and CE T1WI, respectively, and the deep purple ROI represents the necrotic portion within the tumor on CE T1WI. (B) Histology showed a low level of BCAT1 expression.

Back to article page